To clarify for clinicians the information needed to formulate effective, individualized AD management. Interventions and patient education may lead to impressive increases in AD therapy compliance as well as reductions in chronic AD severity, but some come with drawbacks as well as benefits. Atopic Dermatitis (AD) is a common, complex inflammatory skin disease. Optimal management of this complex disease has become increasingly challenging. This presentation will review infection management and how basic therapy of AD addresses skin barrier defects. With the continued development and approval of new therapies for AD, clinicians require comprehensives overviews of all treatments available, comparing benefits and drawbacks. This presentation highlights three 2023 publications in Dermatology Nurse Practice that this presenter contributed to as an author. The series was provided by and accredited by Dermatology Nurses’ Association.

Learning Objectives:
Discuss the relationship between AD and other atopic conditions.
Identify strategies to reduce skin, soft tissue, and systemic infections among patients with AD including stepwise management of atopic dermatitis.
Explore evolving pathways and therapies of AD including newly approved biologics and JAK inhibitors.

ANCC Credits: 1
Pharmacology Credit: 0.5 | 30 mins

Dr. Nicol is Associate Professor Emerita at the University of Colorado College of Nursing in Denver, Colorado. Prior to this position, she was at National Jewish Health and Children’s Hospital Colorado both in Denver. Dr. Nicol is recognized as an international expert on skin health and atopic dermatitis. She is a Past President of the Dermatology Nurses’ Association. Her publications include more than 100 articles and textbook chapters. She is editor-in-chief for the Dermatologic Nursing Essentials 3rd edition textbook for the Dermatology Nurses’ Association. Nothing to disclose.